Fri, Jan 30, 2015, 8:07 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Fibrocell Science, Inc. Message Board

dmesshian 10 posts  |  Last Activity: Nov 16, 2014 9:33 PM Member since: Aug 19, 2011
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Pyott sold 252,000 shares earlier this year

    by gthcgd Nov 16, 2014 5:42 PM
    dmesshian dmesshian Nov 16, 2014 9:33 PM Flag

    Now you are worrying about another man's money? Shame on you. pal.
    There is a strong possibility the announcement will be pre-market opening.
    Let's hope you don't behave like a sour -- sore loser, eh.
    You should move on to the Zoetis mssg board to sell your anti AGN BOD, distortionate comments, while promoting your BFF: Ackman / Pearson roll up scheme.
    I guess we will have to tolerate your presence for one more night, 'cause I know you will be gone once formal details of the deal hits the news wire mañana!

  • Reply to

    AGN has misled investors

    by gthcgd Nov 14, 2014 9:08 AM
    dmesshian dmesshian Nov 16, 2014 12:23 PM Flag

    Your eloquent remarks resonates in hearts of all Allergan shareholders!
    Sir David Pyott and AGN's BOD has added 40+% of value to AGN's shares by doing the necessary work in resisting this hostile takeover by Ackman/VRX.
    They should be lauded for their brilliance and creativity in carrying out their "fiduciary duties" in protecting the rights of all Allergan's shareholders in the face of a great existential challenge.

  • As we all read in the recent Bloomberg summary :
    "The judge who just handed Bill Ackman a legal victory over Allergan (AGN) Inc. may also have given regulators and litigation-minded investors fodder to press insider-trading allegations against the hedge fund manager."
    "Carter also addressed whether Pershing Square violated insider-trading rules by acquiring Allergan stock while preparing a bid with Valeant. Carter’s opinion that there are “serious questions” about this could capture the attention of the U.S. Securities and Exchange Commission and provide a basis for civil claims by investors who’ve missed out on gains Ackman's enjoyed, according to John Coffee, a professor at Columbia University Law School. "

    Judge Carter punted to the SEC. The SEC has its own ongoing investigation.
    Investors can only hope that MLK's famous quote: "the arc of a moral universe is long, but it bends toward justice", holds up in these challenging times.

    See also:

  • Is this the new normal?
    This way, WAY, too EASY MONEY for Ackman!
    This is a no-brainer deal for any investor -- even if he has the IQ of a squid!
    Ackman and Pearson again team up in an "insider trading scheme"!
    How much longer can Government Regulators (SEC), allow this to go on?
    Why does Ackman gets to front run all investors; to secretly accumulate HUGE positions in this back-scratching scheme with Pearson/VRX, and how many of their hedge fund pals are in on these deals?

    Ackman is already camped out in ZTS with the knowledge that his risk profile in these investments is far lesser than any other investor in the investing universe with his access to the "priceless value of perfect prior information" that isn't accorded all investors.

    The SEC need to show some leadership, wisdom and "testicular fortitude", if you will, and step in and halt this gross unfairness before it spreads like a pandemic, causing severe harm to the Markets.
    It's especially demoralizing to retail investors to see this apparent illicit activity going unchecked and is only met with vacillation from the SEC!

  • Reply to

    I call on ophthalmologists....they hate vrx.

    by irishrover0109 Nov 10, 2014 3:32 PM
    dmesshian dmesshian Nov 11, 2014 5:42 PM Flag

    Just the act of issuing this letter with maximum circulation in the media is an indication of more than an isolated perception problem within the ophthalmologists population.
    Where there is smoke, there is fire!
    It's strange that such action would precipitate a rally in VRX's stock; it's not like they issued any data to affect any positive changes in forward financial performance, 'cause this letter is another distressing signal for shareholders.

  • Reply to

    Actavis a rollup

    by gthcgd Nov 7, 2014 4:57 PM
    dmesshian dmesshian Nov 8, 2014 12:04 PM Flag

    Ah, such a deliberate "Freudian slip", from the mind of an Ackman/Pearson plant, attempting to distract and confuse the masses!
    Are you implying that VRX is somehow the lesser of two evils? Spare me the effort 'cause -- by all accounts -- it is not! Please review and compare the balance sheets, and the obvious differences in financial reporting.
    The moderation in tone from your camp, perhaps, is a sign that you finally understand that:
    "He who rides tiger must be wary, lest he ends up inside tiger."

  • dmesshian dmesshian Nov 7, 2014 3:57 PM Flag

    Yeah! Can you imagine that guy?
    He sleeps on the cool side of the pillow, with his 10% stake in AGN stock on the winning side of the risky play.
    While Pearson -VRX sweat it out through sleepless nights.
    Ackman's comes off as a smooth operator -- insider trading and all. he will quietly toast when things blow up on Pearson.

  • Reply to

    Ackman is 100% right - run an auction

    by gthcgd Nov 7, 2014 10:08 AM
    dmesshian dmesshian Nov 7, 2014 12:45 PM Flag

    These flurry of moves smacks of desperation, and Mr. Market has sniffed it out, pal.
    VRX has no prospects for revenue -- top line, nor organic -- growth. Investors are on to the ruse.
    After all, your CEO made his mark as a cost cutter. He is an avowed bottom line specialist guy, that's why he can't grow the top line.
    I see the desperation in your VRX camp, and the urgency is to trade your over-valued VRX stock for AGN's 'cause the Superior CEO, Sir David Pyott ,and AGN's BOD has mastered the formula for delivering growth on both the top and bottom line to keep AGN shareholders happy for as far as the eyes can see.
    Why should AGN stockholders trade their priceless shares for VRX's, "inflated and extremely over-valued stock" at some ridiculous -- debt laden -- inflated offer.
    Please! That's like trying to lure a starving dog off a truck full of the finest cuts of meat!
    It's beginning to get more and MORE absurd...

  • Reply to

    Shareholders win - not Pyott

    by gthcgd Nov 7, 2014 6:31 AM
    dmesshian dmesshian Nov 7, 2014 10:36 AM Flag

    You are spending way so much time commenting about Pyott and Allergan, that you are seemingly unaware of your heightened risk to VRX stock.
    VRX stock is teetering on the brink of serious a decline, if and when any announced move by AGN to consummate a friendly takeover by Actavis of any other suitable union, not VRX.
    That is a very high stakes game at the casino you are playing there, pal. Frankly, I think spending so much of your time and attention, prattling on the AGN mssg board is rather silly, 'cause you are in violation of, rule one of intelligent investing, that is; capital preservation expressed in margin of safety.

    You are wasting your time trying to irritate AGN investors. Their capital is quite well preserve, thanks to the excellent actions of Pyott, and AGN's BOD. Even if AGN decides on a friendly merger with ACT or, another business concern, its shareholders will win, and Sir David Pyott and AGN's BOD will have acted in their best interest in fending off the phantasmagoric alternative of a VRX hostile takeover.
    Can you say the same for the high stakes and riskiest of bet, VRX's mngt has made here?

  • Reply to

    No one won the lawsuit but the lawyers

    by masterofprofit Nov 6, 2014 10:29 AM
    dmesshian dmesshian Nov 6, 2014 1:46 PM Flag

    Yeah, however; this legal expense was justified, given the nature of the existential threat, created by the hostile actions of Ackman/Pearson-VRX!!!
    I am quite sure AGN's shareholders are supportive of Sir David Pyott and AGN's BOD's actions in warding off this threat. Pyott has proven to be a very capable and agile street fighter, if you will -- even out-sluggin' his opponents, on their own turf of choice, that is; the mud pit -- where he now seem to have his opponents in check.

    There is no doubt, that this war is still far from over, however; if the recent slew of news reports, have an iota of truth, we might be very close to -- what would be -- a successful dénouement for .AGN stockholders, as well as, AGN stakeholders -- who are equally of great importance; but have gone relatively unnoticed in this war!

4.14+0.25(+6.43%)Jan 30 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.